Literature DB >> 30933365

Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach.

Belén P Solans1,2, Ascensión López-Díaz de Cerio2,3, Arlette Elizalde4, Luis Javier Pina4, Susana Inogés2,3, Jaime Espinós5, Esteban Salgado6, Luis Daniel Mejías7, Iñaki F Trocóniz1,2, Marta Santisteban2,5.   

Abstract

Entities:  

Keywords:  computational modelling; dendritic cell vaccines; neoadjuvant scenario; pharmacodynamics; pharmacometrics

Mesh：

Substances：

Year:  2019        PMID： 30933365      PMCID： PMC6624395          DOI： 10.1111/bcp.13947

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  41 in total

1.  Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model.

Authors:  P Jacqmin; E Snoeck; E A van Schaick; R Gieschke; P Pillai; J-L Steimer; P Girard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-19       Impact factor: 2.745

2.  Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach.

Authors:  Belén P Solans; Ascensión López-Díaz de Cerio; Arlette Elizalde; Luis Javier Pina; Susana Inogés; Jaime Espinós; Esteban Salgado; Luis Daniel Mejías; Iñaki F Trocóniz; Marta Santisteban
Journal:  Br J Clin Pharmacol       Date:  2019-06-14       Impact factor: 4.335

3.  Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer.

Authors:  N Frances; L Claret; R Bruno; A Iliadis
Journal:  Cancer Chemother Pharmacol       Date:  2011-04-08       Impact factor: 3.333

4.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

5.  Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.

Authors:  Ines Vaz-Luis; Rebecca A Ottesen; Melissa E Hughes; Rizvan Mamet; Harold J Burstein; Stephen B Edge; Ana M Gonzalez-Angulo; Beverly Moy; Hope S Rugo; Richard L Theriault; Jane C Weeks; Eric P Winer; Nancy U Lin
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

6.  Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

Authors:  Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; Søren Buus; Mogens H Claesson
Journal:  Cancer Immunol Immunother       Date:  2004-02-25       Impact factor: 6.968

Review 7.  Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.

Authors:  A S Darwich; K Ogungbenro; A A Vinks; J R Powell; J-L Reny; N Marsousi; Y Daali; D Fairman; J Cook; L J Lesko; J S McCune; Caj Knibbe; S N de Wildt; J S Leeder; M Neely; A F Zuppa; P Vicini; L Aarons; T N Johnson; J Boiani; A Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2017-04-04       Impact factor: 6.875

8.  Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.

Authors:  S E Clark; J Warwick; R Carpenter; R L Bowen; S W Duffy; J L Jones
Journal:  Br J Cancer       Date:  2010-12-07       Impact factor: 7.640

9.  A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.

Authors:  Susana Inogés; Sonia Tejada; Ascensión López-Díaz de Cerio; Jaime Gállego Pérez-Larraya; Jaime Espinós; Miguel Angel Idoate; Pablo Daniel Domínguez; Reyes García de Eulate; Javier Aristu; Maurizio Bendandi; Fernando Pastor; Marta Alonso; Enrique Andreu; Felipe Prósper Cardoso; Ricardo Díez Valle
Journal:  J Transl Med       Date:  2017-05-12       Impact factor: 5.531

10.  Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.

Authors:  Ben O'Leary; Sarah Hrebien; James P Morden; Matthew Beaney; Charlotte Fribbens; Xin Huang; Yuan Liu; Cynthia Huang Bartlett; Maria Koehler; Massimo Cristofanilli; Isaac Garcia-Murillas; Judith M Bliss; Nicholas C Turner
Journal:  Nat Commun       Date:  2018-03-01       Impact factor: 14.919
View more
  4 in total

1.  Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach.

Authors:  Belén P Solans; Ascensión López-Díaz de Cerio; Arlette Elizalde; Luis Javier Pina; Susana Inogés; Jaime Espinós; Esteban Salgado; Luis Daniel Mejías; Iñaki F Trocóniz; Marta Santisteban
Journal:  Br J Clin Pharmacol       Date:  2019-06-14       Impact factor: 4.335

Review 2.  Drug Exposure to Establish Pharmacokinetic-Response Relationships in Oncology.

Authors:  Belén P Solans; María Jesús Garrido; Iñaki F Trocóniz
Journal:  Clin Pharmacokinet       Date:  2020-02       Impact factor: 6.447

3.  Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis.

Authors:  Marta Santisteban; Belén Pérez Solans; Laura Hato; Amaia Urrizola; Luis Daniel Mejías; Esteban Salgado; Rodrigo Sánchez-Bayona; Estefanía Toledo; Natalia Rodríguez-Spiteri; Begoña Olartecoechea; Miguel Angel Idoate; Ascensión López-Díaz de Cerio; Susana Inogés
Journal:  Ther Adv Med Oncol       Date:  2021-12-23       Impact factor: 8.168

Review 4.  The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines.

Authors:  Benjamin Gordon; Vijayakrishna K Gadi
Journal:  Vaccines (Basel)       Date:  2020-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.